Augmedics

Augmedics

Private
Arlington Heights, IllinoisHealthcare & Life Scienceshttps://www.augmedics.com

Last Round

Series D

Jun 27, 2023

Total Funding Raised

$147.8M

Company Overview

Augmedics is a healthcare technology company that develops an augmented-reality surgical visualization system to enhance surgeons' ability to view a patient's anatomy through skin and tissue during procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, AR/VR Hardware, Medical Imaging, Computer Vision, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

augmented reality surgerysurgical navigation systemspine surgeryAR surgeryMedTechimage-guided surgerycomputer-assisted surgeryAR headsetmedical devicesurgical ARxvision Spine Systemrazor-and-blades modelambulatory surgery centersASCsFDA clearance3D anatomical visualization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Augmedics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Augmedics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJun 27, 2023
Series CMar 30, 2021
Series BJun 15, 2020
Series ASep 18, 2017

Key People

Founding team and executive leadership

Gwen Watanabe

Vice Chair From Dec 2024, CEO (Jan 2024 To Dec 2024) And Board Observer (2022 To 2023)

Executive Team

Paul Ziegler

President CEO

Executive Team

Stuart Wolf

CTO

Executive Team

Anna Raz

COO

Executive Team

Augmedics Investors

Notable investors and investment history

InvestorRounds
HCA Healthcare Health Insight CapitalSeries C
Terralab VenturesSeries C, Series A, Series B
Evidity Health CapitalSeries D
Israel Innovation AuthoritySeries A
Revival Healthcare CapitalSeries D, Series C
Almeda VenturesSeries D, Series C
H.I.G. CapitalSeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2025

    First augmented reality surgical navigation device to receive regulatory milestone.

  • Apr 25, 2025

    Launched first-of-its-kind augmented reality surgical navigation device.

Augmedics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Augmedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Augmedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersArlington Heights, Illinois
Employee Range112
Year Founded2014
Last FundingJun 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.